All Articles

VistaShares expands its successful Supercycle® lineup with ETFs for space, defense, and robotics, betting on industry experts over passive indexes.

With its MASH drug Rezdiffra a certified blockbuster, Madrigal's upcoming Q2 report will reveal if its meteoric rise can be sustained against new rivals.

In a strategic move to accelerate expansion, Covo Intelligence hires industry veteran Tony Cheevers to lead growth through deep client partnerships.

The multi-year deal for 285 onshore wells signals a major win for Halliburton’s integrated service model and aligns with Aramco's drive for efficiency.

As Xerox prepares its Q2 report, all eyes are on its digital reinvention. Can the legacy giant prove its IT and AI strategy is paying off?

As OmniAb preps its Q2 results, the real story isn't just the numbers. It's the 'Biological Intelligence' platform reshaping drug discovery from the ground up.

As Black Rock Coffee Bar opens its 58th Phoenix location, a deeper look reveals a strategy built not just on beans, but on a radical culture-first model.

With its lead gene therapy nearing pivotal data, enGene installs a new chairman with a track record of commercial success, signaling a critical shift from R&D to market readiness.

A new report shows 89% of employees trust employer-provided advisors, yet 72% are off-track for retirement. Why the disconnect? It's not about trust, but engagement.

A new technical report revives a historic uranium district, detailing a hunt for a deep geological prize that is central to American Atomics' national strategy.

SYNERGY HomeCare is deploying Sensi.AI's audio intelligence platform across 625 locations, a strategic move to enhance senior care and fight caregiver burnout.

PuraVida Foods' massive expansion wasn't won with promotions. It was earned with performance. A deep dive into the strategy rewriting retail entry rules.

AEROCOR's new buyer's guide for the Phenom 100 isn't just a document; it's a strategic move to replace marketing fluff with hard data in aviation.

Event giant RX Global, producer of New York Comic Con, is moving beyond superheroes to hammers and hardware with its new celebrity-fueled DIY CON in Dallas.

The Department of War has frozen its landmark CMMC program, citing immense costs. Industry applauds the move, but this pause is a critical test for reform.

A new marketing deal between Planet Green and iFLYTEK is more than a contract; it's a story of survival, strategy, and geopolitical risk in tech.

Fresh off a massive Moderna settlement, Arbutus Biopharma expands its patent war against Pfizer and plans a $230M shareholder return, a bold strategic move.

With over $30 billion in credit card rewards unused annually, a new platform is betting its map-based tools can finally turn confusing points into real travel.

Director Grace Sims battled wildfires and managed a surprise pregnancy to finish her debut. Now, 'The Country They Call Life' seeks to reframe a complex debate.

Allstate's massive Q2 catastrophe bill is more than a financial headline. It's a stark signal of a volatile new normal where extreme weather reshapes risk.